Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.5 (2024) • CiteScore: 3.8 (2024) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
The value of time savings in breast cancer therapy for patients and healthcare providers: the subcutaneous injection of pertuzumab and trastuzumab fixed-dose combination at a tertiary care center in the UAE
Khaled H.A. Al Qawasmeh
Journal of Comparative Effectiveness Research
2 Jun 2026
Directly comparing randomized and real-world controls in adjuvant breast cancer
Brigham Walker
,
Marley Boyd
,
Michelle Silver
,
Junxin Shi
,
Purva Bulsara
,
Nino Balanchivadze
, and
Nicholas J Robert
Journal of Comparative Effectiveness Research
29 May 2026
Beyond launch: How real-world evidence is reshaping value assessment
The Evidence Base
Hot off the press: Part one of our pick of articles within HTA and RWE published in May 2026
The Evidence Base
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
Beyond launch: How real-world evidence is reshaping value assessment
Hot off the press: Part one of our pick of articles within HTA and RWE published in May 2026
Understanding real-world data gaps in dementia research for HEOR
Beyond launch: How real-world evidence is reshaping value assessment
Hot off the press: Part one of our pick of articles within HTA and RWE published in May 2026
Evaluating RWE use in health technology assessments submitted to Canada’s Drug Agency
Understanding real-world data gaps in dementia research for HEOR
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– June 2026
How US drug pricing reforms are reshaping biopharma investment and innovation
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
Beyond launch: How real-world evidence is reshaping value assessment
Hot off the press: Part one of our pick of articles within HTA and RWE published in May 2026
Understanding real-world data gaps in dementia research for HEOR
Evaluating RWE use in health technology assessments submitted to Canada’s Drug Agency
.png)
.png)
